Metformin Ct

Metformin Hydrochloride, the active ingredient in Metformin Ct, is a biguanide presented as a tablet for oral use. It reduces blood glucose levels in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Ct as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Ct is indicated for conditions affecting glucose metabolism and insulin sensitivity.

Type 2 diabetes mellitus: improves glycemic control and lowers HbA1c. Prediabetes: helps reduce fasting plasma glucose and delay progression to diabetes. Polycystic ovary syndrome: enhances insulin sensitivity and may aid menstrual regularity.

Metformin Ct may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: persistent metallic sensation in the mouth. - Loss of appetite: reduced desire to eat. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe hypoglycemia: especially when combined with other glucose‑lowering agents. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Allergic reactions: rash, itching, or swelling. - Skin rash: severe cutaneous reactions. - Pancreatitis: inflammation of the pancreas.

Before initiating Metformin Ct, several safety considerations should be reviewed.

Renal function: assess eGFR and avoid use in severe renal impairment. Hepatic function: monitor liver enzymes in patients with liver disease. Cardiovascular status: use cautiously in heart failure due to lactic acidosis risk. Alcohol consumption: limit intake to reduce lactic acidosis risk. Pregnancy and lactation: discuss potential risks with a healthcare provider. Store at ambient temperature: keep in the original pack, protect from moisture.

Metformin Ct can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute kidney injury. - Cimetidine: can increase metformin plasma concentrations. - Nucleoside reverse transcriptase inhibitors: raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics: affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Alcohol: enhances risk of lactic acidosis.